These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2384645

  • 21. [Accelerated desensitization to Dermatophagoides pteronyssinus mites in children with asthma. Results of two years of immunotherapy].
    Le Roux P, Le Luyer B.
    Allerg Immunol (Paris); 1991 Apr; 23(4):135-42. PubMed ID: 2069687
    [Abstract] [Full Text] [Related]

  • 22. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.
    Bousquet J, Hejjaoui A, Clauzel AM, Guérin B, Dhivert H, Skassa-Brociek W, Michel FB.
    J Allergy Clin Immunol; 1988 Dec; 82(6):971-7. PubMed ID: 3204255
    [Abstract] [Full Text] [Related]

  • 23. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E, Eifan AO, Baris S, Gunay E, Akturk E, Akkoc T, Bahceciler NN, Barlan IB.
    J Investig Allergol Clin Immunol; 2015 Dec; 25(5):334-42. PubMed ID: 26727762
    [Abstract] [Full Text] [Related]

  • 24. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects.
    Haugaard L, Dahl R, Jacobsen L.
    J Allergy Clin Immunol; 1993 Mar; 91(3):709-22. PubMed ID: 8454793
    [Abstract] [Full Text] [Related]

  • 25. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
    Delaunois L, Salamon E, Prignot J.
    Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Hyposensitization with extracts of house dust and mites adsorbed on aluminium-hydroxyde (allpyral) in children with bronchial asthma (author's transl)].
    Osváth P, Endre L.
    Monatsschr Kinderheilkd (1902); 1976 Mar; 124(3):110-3. PubMed ID: 1264078
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
    Harmanci K, Razi CH, Toyran M, Kanmaz G, Cengizlier MR.
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):7-13. PubMed ID: 20527510
    [Abstract] [Full Text] [Related]

  • 29. Hyposensitisation with house dust mite vaccine in bronchial asthma.
    Gaddie J, Skinner C, Palmer KN.
    Br Med J; 1976 Sep 04; 2(6035):561-2. PubMed ID: 786429
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma.
    Warner JO, Price JF, Soothill JF, Hey EN.
    Lancet; 1978 Oct 28; 2(8096):912-5. PubMed ID: 81927
    [Abstract] [Full Text] [Related]

  • 32. A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects.
    Price JF, Warner JO, Hey EN, Turner MW, Soothill JF.
    Clin Allergy; 1984 May 28; 14(3):209-19. PubMed ID: 6375890
    [Abstract] [Full Text] [Related]

  • 33. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.
    Des Roches A, Paradis L, Menardo JL, Bouges S, Daurés JP, Bousquet J.
    J Allergy Clin Immunol; 1997 Apr 28; 99(4):450-3. PubMed ID: 9111487
    [Abstract] [Full Text] [Related]

  • 34. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C.
    Am J Respir Crit Care Med; 1994 Jun 28; 149(6):1447-51. PubMed ID: 8004297
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM.
    Nagata M, Yamamoto H, Tabe K, Kimura I, Houya I, Kuramitsu K, Kiuchi H, Yanagihara Y, Sakamoto Y, Yamamoto K.
    Intern Med; 1993 Sep 28; 32(9):702-9. PubMed ID: 8142674
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D, Akmanlar N, Güneşer S, Burgut R, Yilmaz M, Buğdayci R, Aksungur P.
    Allergol Immunopathol (Madr); 1999 Sep 28; 27(6):309-17. PubMed ID: 10611556
    [Abstract] [Full Text] [Related]

  • 40. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT, Iraola V, Himly M, Robinson DS, Badiola C, García-Robaina JC, Briza P, Carnés J.
    Int Arch Allergy Immunol; 2010 Sep 28; 153(1):61-9. PubMed ID: 20357486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.